scholarly journals Prospective cohort study to evaluate the accuracy of sleep measurement by consumer-grade smart devices compared with polysomnography in a sleep disorders population

BMJ Open ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. e044015
Author(s):  
Claire M Ellender ◽  
Syeda Farah Zahir ◽  
Hailey Meaklim ◽  
Rosemarie Joyce ◽  
David Cunnington ◽  
...  

ObjectivesConsumer-grade smart devices are now commonly used by the public to measure waking activity and sleep. However, the ability of these devices to accurately measure sleep in clinical populations warrants more examination. The aim of the present study was to assess the accuracy of three consumer-grade sleep monitors compared with gold standard polysomnography (PSG).DesignA prospective cohort study was performed.SettingAdults undergoing PSG for investigation of a suspected sleep disorder.Participants54 sleep-clinic patients were assessed using three consumer-grade sleep monitors (Jawbone UP3, ResMed S+ and Beddit) in addition to PSG.OutcomesJawbone UP3, ResMed S+ and Beddit were compared with gold standard in-laboratory PSG on four major sleep parameters—total sleep time (TST), sleep onset latency (SOL), wake after sleep onset (WASO) and sleep efficiency (SE).ResultsThe accelerometer Jawbone UP3 was found to overestimate TST by 28 min (limits of agreement, LOA=−100.23 to 157.37), with reasonable agreement compared with gold standard for TST, WASO and SE. The doppler radar ResMed S+ device underestimated TST by 34 min (LOA=−257.06 to 188.34) and had poor absolute agreement compared with PSG for TST, SOL and SE. The mattress device, Beddit underestimated TST by 53 min (LOA=−238.79 to 132) on average and poor reliability compared with PSG for all measures except TST. High device synchronisation failure occurred, with 20% of recordings incomplete due to Bluetooth drop out and recording loss.ConclusionPoor to moderate agreement was found between PSG and each of the tested devices, however, Jawbone UP3 had relatively better absolute agreement than other devices in sleep measurements compared with PSG. Consumer grade devices assessed do not have strong enough agreement with gold standard measurement to replace clinical evaluation and PSG sleep testing. The models tested here have been superseded and newer models may have increase accuracy and thus potentially powerful patient engagement tools for long-term sleep measurement.

2008 ◽  
Vol 23 (9) ◽  
pp. 2050-2055 ◽  
Author(s):  
M.F.G. Verberg ◽  
M.J.C. Eijkemans ◽  
E.M.E.W. Heijnen ◽  
F.J. Broekmans ◽  
C. de Klerk ◽  
...  

2020 ◽  
Vol 17 (1) ◽  
Author(s):  
Michelle Kermode ◽  
Robedi Sharma Choudhurimayum ◽  
Lenin Singh Rajkumar ◽  
Tilahun Haregu ◽  
Greg Armstrong

Abstract Background Opioid substitution therapy (OST) with buprenorphine has been widely available in India since 2007, but the introduction of methadone occurred much later in 2012, and availability remains limited. Illicit injecting drug use is a long-standing public health problem in Manipur, a state in Northeast India characterised by major resource constraints and political unrest. We investigated retention and outcomes for clients attending a methadone-based OST program in Manipur with the aim of strengthening the evidence base for development of relevant policies and programs. Methods All clients enrolling in the methadone clinic over a 1 year period were invited to be part of a prospective cohort study, which followed up and surveyed both retained and defaulting clients for 12 months post-enrollment to assess retention as well as social, behavioural and mental health outcomes. Additionally, we conducted semi-structured qualitative interviews to supplement quantitative information and identify factors contributing to retention and drop-out. Results Of the 74 clients enrolled, 21 had dropped out and three had died (all defaulters) by 12 months post-enrollment, leaving 67.6% still in the program. Using an intention-to-treat analysis, meaningful and statistically significant gains were observed for all social, behavioural and mental health variables. Between baseline and 12 months there were reductions in needle sharing, drug use, property crime, anxiety, depression and suicidal thoughts; and improvements in physical health, mental health, quality of family relationships, employment and hopefulness. Factors contributing to retention and drop-out were identified, including the centrality of family, and general lack of awareness of and misunderstanding about methadone. Conclusion Even in parts of India where resources are constrained, methadone is an effective treatment for opioid dependence. Scaling up the availability of methadone elsewhere in Manipur and in other areas of India experiencing problematic opioid dependence is indicated.


PLoS ONE ◽  
2010 ◽  
Vol 5 (10) ◽  
pp. e13613 ◽  
Author(s):  
Christian Unge ◽  
Björn Södergård ◽  
Gaetano Marrone ◽  
Anna Thorson ◽  
Abigael Lukhwaro ◽  
...  

Author(s):  
Mika Kivimaki ◽  
Marko Elovainio ◽  
Jussi Vahtera ◽  
Marianna Virtanen ◽  
Jane E. Ferrie

2002 ◽  
Author(s):  
A. R. Aro ◽  
H. J. de Koning ◽  
K. Vehkalahti ◽  
P. Absetz ◽  
M. Schreck ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document